SEC Filings TLDR

Magdalene Tong has filed a Schedule 13G with the SEC, disclosing beneficial ownership of 200,000 warrants to purchase shares of common stock in Splash Beverage Group, Inc. The warrants have an exercise price of $0.80 per share. Tong has sole voting and dispositive power over these securities, representing approximately...

The Vanguard Group has filed a Schedule 13G with the SEC, disclosing an increased ownership of 5.21% in Terns Pharmaceuticals Inc. As of September 30, 2025, Vanguard beneficially owns 4,559,917 shares of Terns Pharmaceuticals' common stock, up from 4,306,166 shares previously. This represents a 5.89% increase in shares...

The Vanguard Group has filed a Schedule 13G with the SEC, disclosing an increased ownership stake in Tempus AI Inc. As of September 30, 2025, Vanguard holds 9,441,607 shares of Tempus AI's common stock, representing a 5.59% ownership. This marks a significant increase from their previous holdings, with a 22.07% rise in...

The Vanguard Group Inc has filed a Schedule 13G with the SEC, disclosing an increased stake in TPG RE Finance Trust Inc. As of September 30, 2025, Vanguard Group Inc beneficially owns 3,957,587 shares of TPG RE Finance Trust Inc's common stock, representing a 5.03% ownership stake. This marks an increase of 190,505 sha...

The Vanguard Group has filed a Schedule 13G with the SEC, disclosing a 5.2% ownership stake in Solid Power Inc. The filing, dated October 31, 2025, indicates that The Vanguard Group beneficially owns 9,440,931 shares of Solid Power's common stock. Of these shares, 8,340,594 are held with sole dispositive power, and 1,1...

The Vanguard Group has filed a Schedule 13G with the SEC, disclosing its ownership of 450,993 shares of Smith Douglas Homes Corp's common stock, representing 5% of the total shares outstanding. The filing indicates that Vanguard holds these shares on behalf of its clients, including investment companies and managed acc...

Shay Capital LLC and Shay Capital Holdings LLC have filed a Schedule 13G with the SEC, disclosing their ownership of 7.3% of the common stock of Neuphoria Therapeutics Inc. The filing indicates that Shay Capital LLC holds 171,629 shares, valued at approximately $755,167.6, as of October 31, 2025. Both entities are base...

Magdalene Tong has filed a Schedule 13G with the SEC, disclosing beneficial ownership of 200,000 warrants to purchase shares of common stock in Splash Beverage Group, Inc. The warrants have an exercise price of $0.80 per share. Tong has sole voting and dispositive power over these warrants, which represent approximatel...

The Vanguard Group, Inc. filed a Schedule 13G on October 31, 2025, disclosing its ownership of 2,807,149 shares of Soleno Therapeutics Inc's common stock, representing 5.28% of the total shares outstanding. The filing indicates that Vanguard has sole dispositive power over 2,437,950 shares and shared dispositive power ...

Regal Funds Management Pty Limited filed a Schedule 13G with the SEC, disclosing its ownership of 8,811,766 ordinary shares of Iperionx Ltd, representing 2.63% of the company's outstanding shares. The filing indicates that Regal Funds Management has shared voting and dispositive power over these shares. The shares were...

JPMorgan Chase & Co filed a Schedule 13G on October 31, 2025, disclosing a 5.1% ownership stake in Post Holdings, Inc. The filing indicates that JPMorgan Chase & Co beneficially owns 2,790,694 shares of Post Holdings' common stock. The shares are held through various subsidiaries, including J.P. Morgan Trust Company of...

First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation have jointly filed a Schedule 13G with the SEC, disclosing their ownership of 5.93% of Powell Industries, Inc.'s common stock, amounting to 715,605 shares. The filing is made pursuant to Rule 13d-1(b) and includes a joint filing agreeme...

Agnico Eagle Mines Limited filed a Schedule 13G with the SEC, disclosing its ownership of 10,866,965 common shares of Perpetua Resources Corp., representing 8.71% of the outstanding shares as of October 31, 2025. The filing includes common shares issuable upon the exercise of certain warrants to purchase 2,861,229 comm...

The Vanguard Group Inc has filed a Schedule 13G with the SEC, disclosing an increased stake in OptimizeRx Corp. As of September 30, 2025, Vanguard holds 1,059,109 shares, representing a 5.7% ownership in the company. This marks a 15.01% increase in shares and a 67.06% increase in the value of the holdings compared to t...

First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation have jointly filed a Schedule 13G for OneSpan Inc., disclosing beneficial ownership of 5.63% of the company's common stock, totaling 2,156,973 shares. The filing, made under Rule 13d-1(b), indicates that the shares are held through unit...

The Vanguard Group Inc filed a Schedule 13G form with the SEC, disclosing its ownership of 5.04% of Niagen Bioscience Inc's common stock, amounting to 4,021,650 shares. The filing indicates that Vanguard's clients, including investment companies and managed accounts, have the right to receive dividends or proceeds from...

Baselake Partners, LP, Baselake Management, LLC, and David Paolella have jointly filed a Schedule 13G with the SEC, reporting a 9.4% ownership in Neuphoria Therapeutics Inc. The filing indicates that the shares are held by Baselake Partners, LP, with Baselake Management, LLC serving as the investment manager and David ...

Shay Capital LLC has filed a Schedule 13G with the SEC, disclosing its ownership of 171,629 shares of common stock in Neuphoria Therapeutics Inc., representing 7.3% of the company's outstanding shares. The filing, dated October 31, 2025, indicates that Shay Capital LLC and Shay Capital Holdings LLC, both Delaware entit...

The Vanguard Group Inc has filed a Schedule 13G indicating a significant reduction in its stake in News Corp. As of October 31, 2025, Vanguard holds 9,472,396 shares, representing a 5.03% ownership in the company. This marks a decrease of 42,699,394 shares (81.84%) and a reduction in value by $1,299,716,552.92 (83.82%)...

The Vanguard Group has filed a Schedule 13G with the SEC, disclosing an increased ownership stake in Metsera Inc. As of September 30, 2025, Vanguard holds 5,824,993 shares of Metsera's common stock, representing a 5.53% ownership. This marks a significant increase from their previous holdings, with a 774.86% rise in th...

The Vanguard Group has filed a Schedule 13G with the SEC, disclosing an increased stake in Luminar Technologies Inc. As of September 30, 2025, Vanguard holds 4,234,195 shares, representing 6.62% of the company's common stock. This marks a significant increase from their previous holdings, with a 123.79% rise in the num...

The Vanguard Group has filed a Schedule 13G with the SEC, disclosing an increased ownership stake in Kodiak Gas Services Inc. As of September 30, 2025, Vanguard holds 4,611,188 shares, representing 5.31% of the company's common stock. This marks a significant increase from their previous holdings, with a 41.32% rise in...

JPMorgan Chase & Co. has filed a Schedule 13G with the SEC, disclosing a 5.1% ownership stake in Post Holdings, Inc. as of September 30, 2025. The filing indicates that JPMorgan Chase & Co. beneficially owns 2,790,694 shares of Post Holdings' common stock. Of these shares, 2,556,029 are held with sole voting power, and...

JPMorgan Chase & Co. has filed a Schedule 13G indicating an increase in its ownership of HIMS & HERS HEALTH, INC. The filing reveals that JPMorgan Chase & Co. now owns 17,796,759 shares, representing an 8.1% ownership stake in the company. This marks a significant increase of 6,155,197 shares, or 52.87%, from its previ...

JPMorgan Chase & Co. has filed a Schedule 13G with the SEC, disclosing a 5.3% ownership stake in Hayward Holdings, Inc. as of September 30, 2025. The filing indicates that JPMorgan Chase & Co. beneficially owns 11,641,562 shares of Hayward Holdings' common stock, with sole voting power over 11,052,006 shares and sole d...